Chapter 25 - The Three Factories
Solven-3 had been considered safe.
A degreasing solvent used on protective equipment.
Workers cleaned gloves, boots and respirators with it.
Then wore them home.
Sometimes washed work clothing with family laundry.
The product was common across several industries.
Cole Ceramics.
Aster.
Later Meridian Laboratories.
That explained why cases seemed to jump between companies.
But did Solven-3 cause the weakness?
Leah refused to say.
Historical toxicology showed concerns about one breakdown product.
Animal evidence.
Sparse occupational reports.
No definitive link to the exact neuromuscular pattern.
Thomas looked almost disappointed.
Ethan recognized the emotion.
A lifetime waiting for one culprit.
One label.
One answer big enough to justify everything.
Science did not owe him that.
The new evidence did something more useful.
It showed Project Meridian’s original assumption had been too narrow.
Researchers treated each workplace as separate.
Helen eventually realized some families carried home overlapping exposures across multiple jobs and decades.
That was why she began studying parents.
Not because she had discovered a secret hereditary disease.
Because occupational histories were inherited socially.
A child could be “exposed” without ever entering a factory.
Work boots by the door.
Laundry.
Dust in a car.
Water near company housing.
Household products.
Then later genetics and medication could alter who became symptomatic.
Complicated.
Messy.
Real.
Ethan asked Thomas the question that had bothered him since Chapter 20 of his life—though he would never phrase it that way.
“Why did Mom tell everyone Meridian started with the laboratory accident?”
Thomas answered:
“Funding.”
The company would pay for follow-up only if research centered on its own documented incident.
If Helen said the problem might involve decades of mixed exposures across multiple companies, no single corporation wanted responsibility.
So she anchored the project to the one accident with money attached.
That saved clinical monitoring.
It also distorted the historical record.
Helen became principal investigator because she understood the families better than Samuel did.
Samuel became public director because Helen lacked the academic credentials and feared her connection to Edward created conflict.
The false hierarchy protected the study.
Then became convenient to lawyers.
The photograph of the employees finally made sense.
Not a secret cabal.
A reunion of people who knew the original history before legal departments simplified it.
47-0 was their reminder:
Thomas.
Ward 47.
The sample that started everything.
Ethan felt an unexpected sadness.
So many mysteries turned out to be people improvising.
Some badly.
Some dishonestly.
Some bravely.
Then Leah called.
“We have a problem.”
The independent fund had begun notifying the forty-seven Meridian families about the pre-exposure findings.
One family responded with records of their own.
A woman named Patricia Wynn.
Her son had severe childhood weakness.
Never lived near Cole Ceramics.
Never took yellow tablets.
No known Solven-3 household exposure.
“Then he breaks the pattern,” Ethan said.
“Yes.”
“Good.”
Leah sounded strange.
“Not exactly.”
Patricia’s son carried a rare genetic variant affecting ion transport in muscle.
A variant that could cause episodic weakness independent of environmental exposure.
Ethan closed his eyes.
Genetics returned.
Not as the answer.
As another answer.
Leah tested stored samples from several consenting families.
Thomas carried the same variant.
Edward did not.
Eleanor did.
Ethan did.
Not everyone with the variant had symptoms.
Not every symptomatic Meridian participant carried it.
But in some people, certain medications, illness, injury or environmental stressors could plausibly worsen weakness.
Ethan laughed softly.
Thomas looked at him.
“What?”
“I spent years trying to find the thing that happened to us.”
“And?”
“There wasn't one thing.”
Thomas looked toward the ledger.
“No.”
Multiple pathways had produced similar symptoms.
Some hereditary.
Some exposure-related.
Some medication-associated.
Some injury-amplified.
Meridian’s greatest scientific mistake was grouping them too aggressively.
Its greatest ethical mistake was then hiding uncertainty.
Ethan should have felt closure.
Instead Leah’s next sentence changed everything.
“Thomas’s variant isn't where we expected it.”
“What does that mean?”
“It isn’t on the Cole side.”
Ethan frowned.
Thomas was Edward’s brother.
Same parents.
Or so everyone believed.
Leah continued:
“Archived testing shows their mother didn't carry it.”
“Then their father?”
“No sample.”
Thomas went pale.
There was one person with the exact rare variant and matching surrounding markers.
Eleanor.
Ethan.
And Helen Cole.
Ethan stared.
“My mother?”
“Yes.”
Ethan’s mind rejected the implication.
Helen was not Thomas’s mother.
She had been twenty-two when she met him at Briarwood.
Thomas was sixteen.
Only six years apart.
Impossible.
Unless the shared variant came from somewhere else.
Leah said:
“Ethan, Helen and Thomas may have been related before she ever met him.”
Thomas sat perfectly still.
Then whispered:
“My mother had a younger sister.”
Edward looked at him.
“She died as a baby.”
Thomas shook his head.
“No.”
“I remember her.”
Edward stared.
“You were six.”
“I remember Dad telling me never to ask where she went.”
Thomas looked at Ethan.
“Helen’s maiden name wasn’t Cole.”
“No.”
“What was it?”
Ethan answered.
“Mercer.”
Thomas closed his eyes.
May you like
His mother’s missing sister had been named—
Helen Mercer.
